¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"effective wave length"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
effective wavelength
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
effective renal plasma flow
À¯È¿ÄáÆÏÇ÷ÀåÀ¯·®, À¯È¿½ÅÀåÇ÷ÀåÀ¯·®
effective temperature chart
°¨°¢¿ÂµµÇ¥
effective temperature index
À¯È¿¿ÂµµÁö¼ö
individual effective dose
°³ÀÎÀ¯È¿¿ë·®
minimal effective analgesic concentration
ÃÖ¼ÒÈ¿°úÁøÅë³óµµ
minimal effective dose
ÃÖ¼ÒÀ¯È¿·®
mean effective dose
Æò±ÕÀ¯È¿¼±·®
median effective dose
1. Áß°£À¯È¿¿ë·® 2. Áß°£À¯È¿¼±·®
alpha wave
¾ËÆÄÆÄ
anacrotic wave
»óÇà°¢À¶±â¸ÆÆÄ
biphasic wave form
ÀÌ»ó¼ºÆÄÇü
continuous wave mode
¿¬¼ÓÆÄ¹æ½Ä
continuous wave off-resonance
¿¬¼ÓÆÄÀÌÅ»°ø¸í
delta wave
µ¨Å¸ÆÄ
dicrotic wave
Áߺ¹¸Æ¹ÚÆÄ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
minimal effective dose
ÃÖ¼ÒÀ¯È¿·®
effective mass
À¯È¿Áú·®
effective value
À¯È¿°ª
effective alveolar ventilation
À¯È¿ÆóÆ÷ȯ±â, À¯È¿ÆóÆ÷ȯ±â·®
effective blood volume
À¯È¿Ç÷¾×·®
effective circulating volume
À¯È¿¼øÈ¯¿ëÀû
effective dose equivalent
À¯È¿¼±·®ÇØ´ç·®
effective filtration pressure
À¯È¿¿©°ú¾Ð
effective membrane resistance
À¯È¿¸·ÀúÇ×
effective perceived noise level
½ÇÈ¿°¨¼ö¼ÒÀ½¼öÁØ, ½ÇÁ¦°¨°¢¼ÒÀ½
effective quantum number
À¯È¿¾çÀÚ¼ö
effective renal blood flow
À¯È¿ÄáÆÏÇ÷·ù·®
effective renal plasma flow
À¯È¿ÄáÆÏÇ÷Àå·ù·®
effective temperature index
À¯È¿¿ÂµµÁö¼ö
anacrotic wave
»óÇà°¢À¶±â¸ÆÆÄ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
arterial wave
µ¿¸ÆÆÄ.
arterial wave
µ¿¸ÆÆÄ.
heat wave
¿ÆÄ(Ëç̬).
heat wave
¿ÆÄ(æð÷î).
phrenic wave
Ⱦ°Ý¸·ÆÄµ¿(üô̰د÷îÔÑ).
plane wave
Æò¸éÆÄ(øÁØü÷î).
pulse wave
¸ÆÆÄ(Øæ÷î).
pulse wave velocity
¸ÆÆÄÀüÆÄ¼Óµµ(Øæ÷îï³÷îáÜöô).
pulsed wave Doppler echocardiography
°£ÇæÆÄÇüµµÇ÷¯½ÉÃÊÀ½ÆÄ¼ú(°Ë»ç).
q wave
QÆÄ
q wave,in myocardial infarction
½É±Ù°æ»öÀÇ (QÆÄ)(ãýÐÉÌÛßá¡)
quarter wave Matching
4 ºÐÇÒÆÄ Á¶ÈÃþ
quarter-wave Matching
4-ºÐÇÒÆÄ Á¶ÈÃþ (ÞÌ-ÝÂùÜ÷î ðàûúöµ)
radiofrequency wave
¶óµð¿ÀÆÄ
rapid filling wave
±Þ¼ÓÃæ¸¸ÆÄ.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
optimal length
ÃÖÀû±æÀÌ.
resting length
¾ÈÁ¤½Ã±æÀÌ.
restriction fragment length polymorphism
Á¦ÇѼ¼Æí±æÀÌ´ÙÇü¼º(ð¤ùÚ¼¼Æí¡Òýû¡à÷)
restriction fragment length polymorphism,in cystic fibrosis
³¶¼º¼¶À¯Áõ(ÀÇ)¡(Ò¥àõàéë«ñø¡)
restriction fragment length polymorphism analysis
Á¦ÇÑÀý´Ü±æÀÌ´ÙÇüÁõºÐ¼®
restriction fragment length polymorphism=RFLP
Á¦ÇÑÀýÆí±æÀ̴پ缺
spatial pulse length
°ø°£ ÆÞ½º ±æÀÌ
spatial pulse length
°ø°£ (ÍöÊà) ÆÞ½º ±æÀÌ
tension length curve
Àå·Â-±æÀ̰.
tension length curve
Àå·Â ±æÀ̰
tension length diagram
Àå·Â-À嵵ǥ(íåæ³íþêøú).
tension length diagram curve
Àå·Â-À嵵ǥ°î¼±(¡ÍØàÊ).
biologically effective dose
»ý¹°ÇÐÀûÀ¯È¿¼±·®
collective effective dose
Áý´ÜÀ¯È¿¼±·®
committed effective dose
¿¹Å¹À¯È¿¼±·®
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½